Local and systemic immune responses in mice to intranasal delivery of peptides representing bovine respiratory syncytial virus epitopes encapsulated in poly (dl-lactide-co-glycolide) microparticles

Research in Veterinary Science

Volumn 94, Issue 3, 2013, Pages 809-812

  Kavanagh, Owen V ^a,c   Adair, Brian M ^a,b   Welsh, Michael D ^b   Earley, Bernadette ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

^c ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

Author keywords

Bovine respiratory syncytial virus (BRSV); F fusion glycoprotein; G attachment glycoprotein; Poly(dl lactide co glycolide); Subunit vaccine

Indexed keywords

EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN A ANTIBODY; PEPTIDE ANTIBODY; POLYGLACTIN; PROTEIN G; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CELL MIGRATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG STRUCTURE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; LOWER RESPIRATORY TRACT; MICROENCAPSULATION; MOUSE; NONHUMAN; PNEUMONIA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SPLEEN; SPLEEN CELL; T LYMPHOCYTE; UPPER RESPIRATORY TRACT; VIRAL CLEARANCE;

ANIMALIA; BOVINE RESPIRATORY SYNCYTIAL VIRUS; MUS;

EID: 84876147378     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.12.001     Document Type: Article

References (20)

1. Bastien N., Taylor G., Thomas L.H., Wyld S.G., Simard C., Trudel M. Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host. Vaccine 1997, 15:1385-1390.
2. Bennewitz N.L., Babensee J.E. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 2005, 26:2991-2999.
3. Bryson D.G., Mcferran J.B., Ball H.J., Neill S.D. Observations on outbreaks of respiratory-disease in housed calves.1. Epidemiological, clinical and microbiological findings. Veterinary Record 1978, 103:485-489.
4. Challacombe S.J., Rahman D., O'Hagan D.T. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine 1997, 15:169-175.
5. Jeffery H., Davis S.S., O'Hagan D.T. The preparation and characterization of poly(lactide-co-glycolide) microparticles.2. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharmaceutical research 1993, 10:362-368.
6. Jenkins P.G., Coombes A.G.A., Yeh M.K., Thomas N.W., Davis S.S. Aspects of the design and delivery of microparticles for vaccine applications. Journal of Drug Targeting 1995, 3:79-81.
7. Kavanagh O.V., Earley B., Murray M., Foster C.J., Adair B.M. Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(dl-lactide-co-glycolide) microspheres. Vaccine 2003, 21:4472-4480.
8. Kimman T.G., Westenbrink F., Straver P.J. Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus - effect of amount of virus, virus-replication, route of administration and maternal antibodies. Veterinary immunology and immunopathology 1989, 22:145-160.
9. Kimman T.G., Zimmer G.M., Westenbrink F., Mars J., Vanleeuwen E. Epidemiological-study of bovine respiratory syncytial virus-infections in calves - influence of maternal antibodies on the outcome of disease. Veterinary Record 1988, 123:104-109.
10. Lamm M.E., Nedrud J.G., Kaetzel C.S., Mazanec M.B. Iga and mucosal defense. Apmis 1995, 103(4).
11. Moore A., McGuirk P., Adams S., Jones W.C., McGee J.P., OHagan D.T., Mills K.H.G. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8(+) cytotoxic T lymphocytes and CD4(+) Th1 cells. Vaccine 1995, 13:1741-1749.
12. O' Hagan D.T., Palin K., Davis S.S., Artursson P., Sjoholm I. Microparticles as potentially orally active immunological adjuvants. Vaccine 1989, 7:421-424.
13. Rankin R., Douglas A.J., Foster J.C., Adair B.M. T-cell epitopes of bovine respiratory syncytial virus attachment glycoprotein. Biochemical Society Transactions 1995, 23:S483.
14. Richardson C.D., Scheid A., Choppin P.W. Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides. Virology 1980, 105:205-222.
15. Stott E.J., Taylor G. Respiratory syncytial virus - brief review. Archives of Virology 1985, 84:1-52.
16. Tabata Y., Ikada Y. Phagocytosis of polymer microspheres by macrophages. Advances in Polymer Science 1990, 94:107-141.
17. Taylor G., Thomas L.H., Wyld S.G., Furze J., Sopp P., Howard C.J. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus-infection in calves. Journal of Virology 1995, 69:6658-6664.
18. Thomas L.H., Cook R.S., Howard C.J., Gaddum R.M., Taylor G. Influence of selective T-lymphocyte depletion on the lung pathology of gnotobiotic calves and the distribution of different T-lymphocyte subsets following challenge with bovine respiratory syncytial virus. Research in Veterinary Science 1996, 61:38-44.
19. Valarcher J., Taylor G. Bovine respiratory syncytial virus infection. Veterinary Research 2007, 38:153-180.
20. Yoshida M., Babensee J.E. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. Journal of Biomedical Materials Research 2004, 71A:45-54.